Cargando…

755. Clostridioides difficile Testing and the Use of Laxatives in Immunocompromised Adults

BACKGROUND: Clostridioides difficile infection (CDI) rates have plateaued at historical highs in the United States since 2010 and remains a major health problem. While optimal CDI testing remains unclear, current literature recommends testing patients whose symptoms are not clinically attributable t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Al-Bahou, Amanda, Quilitz, Rod, Pasikhova, Yanina, Greene, John
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Poster Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644424/ http://dx.doi.org/10.1093/ofid/ofab466.952

Ejemplares similares

1301. Breakthrough Invasive Fungal Infections based on CYP2C19 Levels in Patients Who were on Voriconazole as Primary Antifungal Prophylaxis in Acute Myeloid Leukemia (AML) undergoing Induction Chemotherapy
por: Singam, Hareesh v, et al.
Publicado: (2020)

742. Breakthrough Invasive Fungal Infections with Isavuconazonium Sulfate versus Voriconazole as Primary Antifungal Prophylaxis in Patients with Acute Myeloid Leukemia (AML) who Received Induction Chemotherapy
por: Singam, Hareesh v, et al.
Publicado: (2020)

71. Diagnostic Stewardship of Clostridioides difficile Testing
por: Qamar, Zahra, et al.
Publicado: (2021)

483. Use of Terbinafine in Combination with Other Systemic Anti-fungal Agents As Treatment for Invasive Mold Infections. Experience from A National Cancer Institute Designated Cancer Center.
por: Ajayi, Eloho, et al.
Publicado: (2022)

1376. Oral Vancomycin as Secondary Prophylaxis Against Clostridioides difficile Infection in Pediatric Patients
por: Bao, Hongkai, et al.
Publicado: (2020)

104. Evaluation of a 2-Step Testing Algorithm for Clostridioides difficile Infection
por: Bettger, Caitlin C, et al.
Publicado: (2020)

An Osmotic Laxative Renders Mice Susceptible to Prolonged Clostridioides difficile Colonization and Hinders Clearance
por: Tomkovich, Sarah, et al.
Publicado: (2021)

752. Costs Attributable to Clostridioides difficile Infection in the Presence of Differential Mortality
por: Sahrmann, John, et al.
Publicado: (2021)

1197. Inhibitory Effect of Ursodeoxycholic Acid on Clostridioides difficile Growth
por: Alnezary, Faris, et al.
Publicado: (2020)

783. Clostridioides difficile Infection among Maintenance Hemodialysis Patients
por: Radhakrishnan, Parvathi, et al.
Publicado: (2020)

2347. Impact of Multidisciplinary Review of Clostridioides difficile Testing
por: Foreman, Jena, et al.
Publicado: (2019)

120. Stewardship Driven Reduction of Inappropriate Clostridioides difficile Testing at a Tertiary Military Medical Facility
por: Gilbert, Laura, et al.
Publicado: (2020)

784. A Novel Method to Assess Virulence of Clostridioides difficile: Focus on C. difficile Ribotype 106
por: Almutairi, Masaad, et al.
Publicado: (2020)

1416. Assessing the potential for interspecies transmission of Clostridioides difficile on dairy farms
por: Redding, Laurel, et al.
Publicado: (2020)

12. Randomized Studies of Two Clostridioides (Clostridium) difficile Vaccine Formulations
por: Lawrence, Jody, et al.
Publicado: (2020)

801. Patients with Clostridioides difficile Infection Following Dental Antibiotic Prescription
por: Wilson, Geneva M, et al.
Publicado: (2020)

675. Evaluation of PLST for Clostridioides difficile Sequence-based Strain Typing
por: Edlind, Tom, et al.
Publicado: (2020)

789. Evaluation of Bezlotoxumab for Prevention of Recurrent Clostridioides difficile Infection in Patients at High Risk for Recurrence
por: Johnson, Tanner M, et al.
Publicado: (2020)

974. Real World Experience of Posaconazole Therapeutic Drug Monitoring in Oncology Patients: Clinical Implications of Hypoalbuminemia as a Predictor of Subtherapeutic Posaconazole Levels
por: Pasikhova, Yanina, et al.
Publicado: (2023)

788. Evaluation of a Multiplex PCR Panel and Confirmatory Cytotoxin Testing on Clostridioides difficile at a Pediatric Hospital
por: Lauth, Michael J, et al.
Publicado: (2020)

751. Impact of Changing from a Three-step to Two-step Testing Algorithm for the Diagnosis of Clostridioides difficile
por: Lapin, Jonathan, et al.
Publicado: (2021)

787. Evaluation of Clostridioides difficile Environmental Contamination Surrounding C. difficile Patients vs. non-C. difficile Patients in Outpatient Infusion Centers
por: Garey, Kevin W, et al.
Publicado: (2020)

722. Effectiveness of Fidaxomicin versus Oral Vancomycin in the Treatment of Recurrent Clostridioides difficile
por: Rinaldi, Alyssa, et al.
Publicado: (2020)

804. Use of a Trained Canine to Detect Clostridioides difficile in the Hospital Environment
por: Harrison, Rachael M, et al.
Publicado: (2020)

740. Elucidation of the Mode of Clostridioides difficile Transmission Based on One Health Approach
por: Yoshizawa, Sadako, et al.
Publicado: (2021)

98. Outcomes of Clinical Decision Support for Outpatient Management of Clostridioides difficile Infection
por: Wu, Tiffany, et al.
Publicado: (2021)

62. Secondary Prophylaxis in Clostridioides difficile Infections: a Closer Look at Outcomes
por: Rodriguez, Rubi, et al.
Publicado: (2021)

668. The clinical effectiveness of Fidaxomicin compared to Vancomycin in the treatment of Clostridioides difficile infection in immunocompromised hosts, a single center study
por: Alsoubani, Majd, et al.
Publicado: (2023)

1710. Clostridioides difficile Bundle Implementation Reduces Unnecessary Testing in Pediatric Patients
por: Sietsema, Lydia, et al.
Publicado: (2023)

756. Clostridioides difficile Burden of Disease: A Prospective Population-Based Surveillance Study of Hospitalized Adults in Louisville, Kentucky
por: Furmanek, Stephen, et al.
Publicado: (2021)

129. Evaluation of Two-Step Clostridioides difficile Testing on Treatment Exposure
por: Bennett, Nicholas, et al.
Publicado: (2023)

729. Real World Efficacy of Bezlotoxumab for Prevention of Clostridioides Difficile Recurrence in Immunosuppressed Patients
por: Perreault, Sarah, et al.
Publicado: (2020)

875. Pseudo-outbreak of Clostridioides (Clostridium) difficile amongst post-operative Oncology Patients
por: Kagedan, Daniel, et al.
Publicado: (2020)

782. Clostridioides difficile environmental contamination in hospitalized patients with diarrhea: a pilot study
por: Warren, Bobby G, et al.
Publicado: (2020)

P26 Phenotypic and genotypic characterization of antimicrobial resistance in Clostridioides difficile in North Wales
por: Thomas, R., et al.
Publicado: (2022)

1037. Efficacy of Germinants and Omadacycline for Preventing Clostridioides difficile Relapse in a Murine Model
por: Budi, Noah, et al.
Publicado: (2021)

1001. Chronic Colonization with Toxigenic Clostridioides difficile Strains Drives Colonic Tumorigenesis in Mice
por: Drewes, Julia L, et al.
Publicado: (2021)

792. Evaluation of Persistent Diarrhea and Recurrence Following Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection
por: Boton, Noah, et al.
Publicado: (2020)

2412. Oral Vancomycin Prophylaxis Against Recurrent Clostridioides difficile Infection: Efficacy and Side-effects: Two Hospitals Experience
por: Zacharioudakis, Ioannis, et al.
Publicado: (2019)

657. Impact of Oral Vancomycin Duration on Clostridioides difficile Recurrence in Patients Requiring Concurrent Systemic Antibiotics
por: Marsh, Kassandra, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_4ribp4jh0ndaufmadrblvtskfd